Delivery Order SPE2DR25D3017-SPE2DR26F3EF8
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $1,392.76 to AmerisourceBergen Drug Corp for Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) on December 10, 2025, with a completion date of December 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a contract ceiling value of $1,973.26. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,185.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,973.18 and a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for ultimate completion by December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,751.28 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 30 mg capsules (100 count) on December 10, 2025, with completion scheduled for December 11, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,310.10 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $3,449.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count). The contract is a non-set-aside competitive award with a completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for dextroamphetamine-amphetamine 25 mg capsules (100-count units) with a ceiling value of $1,423.22. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 23, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3EF8Delivery Order
The Defense Logistics Agency awarded a $3,103.86 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for dextroamphetamine-amphetamine 25 mg capsules (100 count). This non-set-aside, competitively awarded contract features firm fixed pricing and is scheduled for completion by December 4, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major healthcare solutions provider and distributor. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen Drug Corp's federal contracting portfolio demonstrates its critical role in the military supply chain, with consistent awards reflecting open competition and firm fixed-price delivery arrangements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/2/25 |